Greway A T, Mentzer M, Levy M A
Department of Medicinal Chemistry, Smith Kline & French Laboratories, King of Prussia, PA 19406-0939.
Biochem Int. 1990;20(3):591-7.
An analogue of androstenedione containing an ethano bridge between carbons 2 and 10 of the A ring of the steroid, 1, has been evaluated as an inhibitor and a possible substrate of human placental aromatase. This compound was found to be a competitive inhibitor versus androstenedione (Kis = 25 +/- 2 nM) of the aromatase activity. Analyses of the incubation mixtures of 1 with human placental microsomes and NADPH by GC-MS indicated the formation of a new compound having an increase in molecular weight of 2 mass units (300 m.u.) from that of the parent steroid (298 m.u.). Subsequent analyses of incubations of 1 with an isolated 17 beta-hydroxysteroid dehydrogenase (17 beta-HSD) from Pseudomonas testosteronii in the presence of NADPH resulted in the formation of a new compound having the same retention time and molecular mass as that found for the product from the placental microsome incubation. Consequently, steroid 1 is both an inhibitor of human placental aromatase and a substrate for 17 beta-HSD.
一种甾体A环的碳2和碳10之间含有乙桥的雄烯二酮类似物(1),已被评估为人类胎盘芳香化酶的抑制剂和可能的底物。该化合物被发现是芳香化酶活性相对于雄烯二酮的竞争性抑制剂(Kis = 25 +/- 2 nM)。通过气相色谱 - 质谱联用(GC-MS)对1与人胎盘微粒体和NADPH的孵育混合物进行分析,结果表明形成了一种新化合物,其分子量比母体甾体(298 m.u.)增加了2个质量单位(300 m.u.)。随后在NADPH存在下,对1与来自睾丸酮假单胞菌的分离的17β-羟基类固醇脱氢酶(17β-HSD)进行孵育分析,结果形成了一种新化合物,其保留时间和分子量与胎盘微粒体孵育产物相同。因此,甾体1既是人类胎盘芳香化酶的抑制剂,也是17β-HSD的底物。